PFIZER $29.68

up +0.28


19/6/2013 01:19 PM  |  NYSE : PFE  |  Industries : Manufacturing / Pharmaceutical and Medicine Manufacturing
Last Trade: 29.68
Trade Time: Jun 19 1:30 PM Eastern Daylight Time
Change: 0.28 (0.95 %)
Prev Close: 29.40
Open: 29.37
Bid: 29.67
Ask: 29.68
Quotes displayed are delayed by 15 minutes. Market data is provided by Telvent DTN
Get Trend Analysis Icon Get PFE Trend Analysis - it has outperformed the S&P 500 by 8%

ETF Alternatives



People viewing PFE also viewed: , , , ,

Competitors

Ticker Name Volume % Change
ACEL TAMIR BIOTECHNOLOGY 5.5K +1.50%
CKGT CHINA KANGTAI CACTUS BIO 500.0 +1.11%
CNSO CNS RESPONSE 100.0 +0.65%
TRGM TARGETED MEDICAL PHARMA 30.2K +0.64%
MLHI MILLENIA HOPE 2.0K +0.54%

Insider Transactions

Date Name Title Volume Trade Price Holding Change
5/15/2013 READ IAN C Chairman & CEO -19,400 $29.48 -1.79%
5/15/2013 SCHULMAN AMY W Executive Vice President -4,500 $29.29 -1.70%
5/15/2013 SCHULMAN AMY W Executive Vice President -3,999 $29.36 -1.49%
5/15/2013 READ IAN C Chairman & CEO -700 $29.47 -0.06%
5/15/2013 READ IAN C Chairman & CEO -705 $29.32 -0.06%
Data provided by Insiderslab.com. To read detailed Insider Trading Research Report for (PFE), click here.
View All

PFE Stock Analysis

  1. Ariad's Iclusig in GIST Phase II Study - Analyst Blog

    (PFE,NVS,ARIA,JAZZ )
    The study will evaluate Iclusig's efficacy and safety in patients who have failed at least one tyrosine kinase inhibitor therapy.
  2.

    Apremilast Data Presented by Celgene - Analyst Blog

    (PFE,CELG,AMGN,BIIB )
    Celgene presented data from the PALACE 3 study on apremilast.
  3.

    Lilly Alzheimer's Study Terminated - Analyst Blog

    (PFE,LLY,NVO,JNJ )
    The phase II study was voluntarily terminated due to the identification of abnormal liver biochemical tests during routine monitoring.
  4.

    $2.15B Settlement for Pfizer's Protonix - Analyst Blog

    (PFE,TEVA,MYL,TKPYY )
    While Teva will make a payment of $1.6 billion, Sun Pharma will pay the remaining $550 million.

  5. CRL for AVEO/ALPMY's Tivozanib - Analyst Blog

    (AVEO,ALPMY,SNTS,PFE )
    AVEO Pharmaceuticals, Inc. and Astellas Pharma, Inc. received a complete response letter for tivozanib from the US FDA.

  6. Encouraging Data on Novartis Candidate - Analyst Blog

    (NVS,RHHBY,PFE,SLXP )
    Novartis (NVS) recently released encouraging data on its pipeline candidate, LDK378, from a phase I study.
Free Reports
  1.

    FREE Options Trading Manual

    If you are new to the options market, this free booklet is designed for you!
  2.

    7 Proven Strategies for Market-Stomping Stocks

    Discover Investing Strategies that will Benefit Every Investor Today!
  3.

    Find the Best Mortgage Rates

    Search and compare the best fixed and adjustable mortgage rates in your area with Bankrate.com.
Marketplace
Trading Center